Suchergebnisse - "Li, Michael"

PubPharm (705)

61

The association between childhood adversity and the conserved transcriptional response to adversity (CTRA) in sexual minority men

enthalten in: Research square | 2023

von Dalvie, S. | Li, M. | Kalmin, M. | +3

62

Evaluating undercounts in epidemics : Response to Maruotti et al. (2022)

enthalten in: Journal of medical virology | 2023

von Li, M. | Dushoff, J. | Earn, D. | +1

CommentOn: J Med Virol. 2023 Jan;95(1):e28099. - PMID 36029120

63

A review of factors associated with methadone maintenance treatment adherence and retention in Vietnam

enthalten in: Drug and alcohol dependence | 2023

von Nong, T. | Hodgkin, D. | Trang, N. | +4

64

Associations between Lifestyle Factors and Neurocognitive Impairment among Chinese Adolescent and Young Adult (AYA) Survivors of Sarcoma

enthalten in: Cancers | 2023

von Cheung, Y. | Ma, C. | Li, M. | +5

65

Treatment of insomnia in myasthenia gravis-A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia

enthalten in: Frontiers in neurology | 2023

von Yan, J. | Yang, M. | Li, M. | +7

66

Data-driven COVID-19 vaccine development for Janssen

enthalten in: INFORMS journal on applied analytics | 2023

von Bertsimas, D. | Li, M. | Liu, X. | +2

67

Forecasting COVID-19 and analyzing the effect of government interventions

enthalten in: Operations research | 2023

von Li, M. | Bouardi, H. | Lami, O. | +3

68

Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery

Erschienen: [S.l.], SSRN, [2023]

MIT Sloan Research Paper - No. 6858-23

von Barberio, J. | Becraft, J. | Ben Chaouch, Z. | +6

69

Response to induction chemotherapy in sinonasal malignancies : A single‐institutional experience

enthalten in: Head & Neck | 2023

von Nyirjesy, S. | Fenberg, R. | Heller, M. | +6

70

Evaluating undercounts in epidemics : Response to Maruotti et al. (2022)

enthalten in: Journal of Medical Virology | 2023

von Li, M. | Dushoff, J. | Earn, D. | +1